Financial Partners Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $9.65M | Sell |
73,514
-1,708
| -2% | -$224K | 2.15% | 14 |
|
|
2022
Q3 | $8.8M | Sell |
75,222
-975
| -1% | -$114K | 2.08% | 18 |
|
|
2022
Q2 | $8.96M | Buy |
76,197
+185
| +0.2% | +$21.8K | 1.93% | 19 |
|
|
2022
Q1 | $9.9M | Sell |
76,012
-53
| -0.1% | -$6.91K | 1.84% | 22 |
|
|
2021
Q4 | $11.6M | Buy |
76,065
+2,397
| +3% | +$366K | 2.06% | 17 |
|
|
2021
Q3 | $11.9M | Sell |
73,668
-720
| -1% | -$116K | 2.18% | 16 |
|
|
2021
Q2 | $12.2M | Sell |
74,388
-846
| -1% | -$138K | 2.24% | 17 |
|
|
2021
Q1 | $11.3M | Sell |
75,234
-270
| -0.4% | -$40.7K | 2.29% | 15 |
|
|
2020
Q4 | $11.4M | Sell |
75,504
-825
| -1% | -$125K | 2.61% | 15 |
|
|
2020
Q3 | $10.3M | Sell |
76,329
-1,200
| -2% | -$162K | 2.75% | 12 |
|
|
2020
Q2 | $10.6M | Buy |
77,529
+149
| +0.2% | +$20.4K | 3.05% | 11 |
|
|
2020
Q1 | $8.34M | Buy |
+77,380
| New | +$8.34M | 2.66% | 11 |
|
|
2018
Q4 | $6.99M | Buy |
72,510
+26,345
| +57% | +$2.54M | 2.3% | 20 |
|
|
2018
Q3 | $5.63M | Buy |
+46,165
| New | +$5.63M | 1.6% | 29 |
|
|
2017
Q1 | – | Sell |
-17,145
| Closed | -$1.52M | – | 112 |
|
|
2016
Q4 | $1.52M | Buy |
+17,145
| New | +$1.52M | 0.36% | 60 |
|